# What cervical cancer screening costs patients at the Senkatana centre, Lesotho

Source: https://onco.cc/key-papers/paper-sefuthi-patient-costs-cervical-screening-lesotho-fph-2026/  
OnCo record `paper-sefuthi-patient-costs-cervical-screening-lesotho-fph-2026` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A 2025 survey of 100 women screened for cervical cancer in Maseru found the average visit cost the patient about 21 international dollars, almost all of it in indirect costs and lost productivity, and that results took a month on average.

## Summary

Published as "A patient costing analysis of Lesotho's cervical cancer screening program". Women using screening services at the Senkatana Cervical Cancer Center of Excellence between January and November 2025 were asked about direct, indirect and productivity costs to themselves and their caregivers. Costs were converted to international dollars using 2024 purchasing power parity. The authors are at Stellenbosch University.

## Fields

- Kind: Key paper
- Last checked: 2026-11-16
- Journal: Frontiers in Public Health
- Year: 2026
- DOI: 10.3389/fpubh.2026.1888325
- Authors: Sefuthi T, Van Schalkwyk C, Nkonki L.
- Findings: 46% were screened with a Pap smear, 44% with HPV DNA testing and 9% with visual inspection with acetic acid; 3% received loop excision treatment.; 91% had to return to collect results, with a mean turnaround of 32.4 days.; Mean total cost per patient per visit was $21.4 (95% CI 17.42 to 25.98): indirect costs 52%, productivity costs 44%, direct medical costs 4%.; Across screening and treatment the estimated cost was $62.3 for the Pap smear route, $61.7 for HPV testing and $41.2 for visual inspection, about 17%, 17% and 11% of average monthly income.
- What it means: Medical fees were a small part of what screening cost these women (4%); the rest was indirect costs and lost productivity, and nine in ten had to make a second trip for results. The authors argue that patient costs belong in screening policy and economic evaluations.
- Caveats: 100 women at one centre in the capital.; Costs for the full screening-to-treatment route are extrapolated; 3% of the women had treatment.; The abstract names the Senkatana Cervical Cancer Center of Excellence. It is linked here to the Senkatana Oncology Clinic record because both are at Senkatana in Maseru; OnCo has not confirmed that they are one unit.

## Sources

- Front Public Health 2026: https://doi.org/10.3389/fpubh.2026.1888325
- PubMed: https://pubmed.ncbi.nlm.nih.gov/42952594/

## Connected records

- key papers: [Barriers to cancer services reported by patients at the Senkatana oncology clinic, Lesotho](https://onco.cc/key-papers/paper-ramathebane-barriers-cancer-services-lesotho-sajo-2024/), [Cervical cancer screening uptake in Lesotho in the 2024 Demographic and Health Survey](https://onco.cc/key-papers/paper-wassie-cervical-screening-lesotho-dhs-bmcph-2025/)
- cancers: [Cervical cancer](https://onco.cc/cancers/cervical/)
- institutions: [Senkatana Oncology Clinic](https://onco.cc/institutions/senkatana-oncology-clinic/)

---
JSON: https://onco.cc/api/v1/entities/paper-sefuthi-patient-costs-cervical-screening-lesotho-fph-2026.json